Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer With Malignant Ascites”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Ended earlyNCT02417753
What this trial is testing

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Who this might be right for
Ovarian CancerOvarian NeoplasmsAscites+2 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT02540356
What this trial is testing

Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

Who this might be right for
Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
Baxalta now part of Shire 2
Large-scale testing (Phase 3)Study completedNCT00327444
What this trial is testing

Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian NeoplasmsAscites
Sanofi 58
Testing effectiveness (Phase 2)Study completedNCT02122185
What this trial is testing

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Brenner TumorMalignant AscitesMalignant Pleural Effusion+25 more
University of Chicago 111
Not applicableEnded earlyNCT03189108
What this trial is testing

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer+1 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Looking for participantsNCT07435701
What this trial is testing

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Who this might be right for
Ovarian Neoplasms MalignantAscites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Testing effectiveness (Phase 2)UnknownNCT01838538
What this trial is testing

Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy

Who this might be right for
Ovarian Cancer With Malignant Ascites
Chinese PLA General Hospital 54
Testing effectiveness (Phase 2)Study completedNCT00396591
What this trial is testing

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian Neoplasms
Sanofi 16
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Early research (Phase 1)Study completedNCT00002960
What this trial is testing

SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Merck Sharp & Dohme LLC 59
Testing effectiveness (Phase 2)Study completedNCT00326885
What this trial is testing

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Who this might be right for
Malignant Ascites
Neovii Biotech 32
Testing effectiveness (Phase 2)Study completedNCT06266091
What this trial is testing

Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

Who this might be right for
Malignant Ascites
Wuhan YZY Biopharma Co., Ltd. 115